Cargando…
Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis
Nearly 50% of patients with systemic lupus erythematosus (SLE) will develop lupus nephritis (LN). Current treatment regimens for LN are suboptimal as the majority of patients fail to achieve complete renal response after several months of treatment and there are high rates of relapse. We report outc...
Autores principales: | Baum, Rebecca, Geetha, Duruvu, Fatola, Ayotola, Timlin, Homa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256255/ https://www.ncbi.nlm.nih.gov/pubmed/37303434 http://dx.doi.org/10.7759/cureus.38848 |
Ejemplares similares
-
Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA
por: Auguste, Bourne, et al.
Publicado: (2021) -
The Role of Belimumab in Systemic Lupus Erythematosis: A Systematic Review
por: Joy, Ashna, et al.
Publicado: (2022) -
Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus
por: Dein, Eric, et al.
Publicado: (2018) -
Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019) -
Clinical Characteristics of Hydralazine-induced Lupus
por: Timlin, Homa, et al.
Publicado: (2019)